Gene · 11140
Papers1,640
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,640
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular mechanism of PINK1 regulation by the Hsp90 machinery. | Nat Commun | 2025 | 41326378 | PubTator, text mining | PubMed |
| Heat Stress Induces Partial Resistance to Tomato Bushy Stunt Virus in Nicotiana benthamiana Via Combined Stress Pathways. | Viruses | 2025 | 41012677 | PubTator, text mining | PubMed |
| Integrating single-cell transcriptomics, molecular docking, and dynamics simulations to characterize protein kinase X-linked mechanisms in osteosarcoma. | Int J Biol Macromol | 2025 | 40907924 | PubTator, text mining | PubMed |
| Alphappimi: a comprehensive deep learning framework for predicting PPI-modulator interactions. | J Cheminform | 2025 | 40883823 | PubTator, text mining | PubMed |
| Design of multi-target peptide modulators for protein chaperone networks. | Structure | 2025 | 40858118 | PubTator, text mining | PubMed |
| Ginsenoside Rg5 enhances Abemaciclib sensitivity in ER+ breast cancer by modulating cell cycle proteins via transcriptional and post-translational levels. | J Ginseng Res | 2025 | 40843016 | PubTator, text mining | PubMed |
| Construction and validation of acetylation-related gene signatures for immune landscape analysis and prognostication risk prediction in luminal breast cancer. | Cancer Cell Int | 2025 | 40722090 | PubTator, text mining | PubMed |
| The KRAS p.Ala146Thr mutation promotes the proliferation of colorectal cancer cells via CDK1-mediated ERK signaling. | Cancer Genet | 2025 | 40706337 | PubTator, text mining | PubMed |
| Disrupting the Hsp90-Cdc37 axis: a selective strategy for targeting oncogenic kinases in cancer. | RSC Adv | 2025 | 40491798 | PubTator, text mining | PubMed |
| Utilizing Multi-omics analysis to elucidate the role of mitochondrial gene defects in Gastric cancer progression. | PLoS One | 2025 | 40489463 | PubTator, text mining | PubMed |
| Discovery of new celastrol derivatives with antitumor activity in vitro and invivo by blocking Hsp90-Cdc37-kinase cycle. | Eur J Med Chem | 2025 | 40472487 | PubTator, text mining | PubMed |
| Dual-Site Targeting by Peptide Inhibitors of the N-Terminal Domain of Hsp90: Mechanism and Design. | J Chem Inf Model | 2025 | 40310892 | PubTator, text mining | PubMed |
| Structural Optimization of Pyrazole Compounds as Hsp90 Regulators with Enhanced Antitumor Activity. | J Med Chem | 2025 | 40310691 | PubTator, text mining | PubMed |
| Effect of the CSFV NS5A protein on key proteins in the MAPK and PI3K-mTOR signaling pathways in porcine macrophages. | Front Microbiol | 2025 | 40078537 | PubTator, text mining | PubMed |
| Differential scanning fluorimetry followed by microscale thermophoresis and/or isothermal titration calorimetry as an efficient tool for ligand screening. | Biophys Rev | 2025 | 40060009 | PubTator, text mining | PubMed |
| A Practical Approach to Quantitatively Assessing Equilibrium-Constant Accuracy from a Single Binding Isotherm. | Precis Chem | 2025 | 40018450 | PubTator, text mining | PubMed |
| Purification and characterization of full-length monomeric TEC family kinase, ITK. | Protein Expr Purif | 2025 | 39894064 | PubTator, text mining | PubMed |
| Mechanism of chaperone recruitment and retention on mitochondrial precursors. | Mol Biol Cell | 2025 | 39878680 | PubTator, text mining | PubMed |
| Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment. | Pharmacol Res | 2025 | 39667542 | PubTator, text mining | PubMed |
| Allosteric CDC37 Inhibitor Disrupts Chaperone Complex to Block CDK4/6 Maturation. | Angew Chem Int Ed Engl | 2025 | 39582167 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11140/papers?page=2